Back to search

Cornell University

DEVELOPMENT OF LOW-COST, MICRO-VOLUME ANTIMICROBIAL RESISTANCE ASSAYS FOR PATHOGENIC BACTERIA

Abstract

dc:description.abstract

A lack of diagnostics and growing antibiotic resistance worldwide threatens to make once treatable disease deadly again. The discovery of antibiotics drastically reduced the mortality of bacterial infectious diseases; however, persistence is still rampant in low- and middle-income countries. Even when infections are properly diagnosed and treatments are available, resistance genes are spreading and leading to more treatment failures. Paper-based diagnostics require no cold chain or power supply and are magnitudes cheaper than standard nucleic acid amplification techniques. They are also easier to perform and run faster than typical cell culture-based diagnostics. Thus, paper diagnostics provide global solutions to curbing bacterial diseases. In this work, I describe efforts to develop low cost, accessible technologies for identifying the presence and the antimicrobial susceptibility profile of various pathogenic bacteria on the World Health Organizations top threat list. Specifically, I focus on Carbapenem-resistant Enterobacterales (CRE), a group of bacteria commonly responsible for hospital acquired infections, and Neisseria gonorrhoeae, the causative agent of the sexually transmitted infection gonorrhea. First, I describe a paper-based chip made of chromatography paper and wax that supports the growth of CRE in the presence of three different clinically relevant antibiotics at three concentrations each. For the low cost of $0.77, this technology can enable personalized antibiotics prescriptions by giving personalized susceptibility information to prescribing clinicians. Next, I describe the evaluation of various colorimetric dyes capable of indicating viability of N. gonorrhoeae. By focusing on dyes that can be seen with the naked eye, we aim to reduce the need for complex equipment and reduce the level of training required for end users. Thirdly, I developed a lateral flow assay to detect the presence of Neisseria gonorrhoeae quickly and accurately in a sample and concentrate and isolate whole, live bacteria that can be used in downstream susceptibility testing. Finally, I combine these technologies to develop a paper chip for antibiotic susceptibility testing of N. gonorrhoeae.

Degree

thesis:*
Name thesis:degree_name
Ph. D., Biomedical Engineering
Level thesis:degree_level
Doctor of Philosophy
Discipline thesis:degree_discipline
Biomedical Engineering
Grantor
Cornell University
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Oeschger, Taylor
Chair dc:contributor.chair
  • Erickson, David
Committee members dc:contributor.committeemember
  • Kirby, Brian
  • August, Avery

Subjects

dc:subject × 4

Rights

dc:rights
Statement dc:rights
  • Attribution 4.0 International
Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Bibid
15529849
Dc Identifier Other
ProQuest Submission ID: 13042
ProQuest Publication ID: 29167475

Chain of custody

source
Harvested from
Cornell University
Base URL
ecommons.cornell.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Oeschger, Taylor. DEVELOPMENT OF LOW-COST, MICRO-VOLUME ANTIMICROBIAL RESISTANCE ASSAYS FOR PATHOGENIC BACTERIA. Doctor of Philosophy thesis, Cornell University, 2022. https://hdl.handle.net/1813/111767